Key figures

Share this page

IR - Key figures
Key figures

All key figures as of December 31. If you're looking for further financial information, please visit our financial reports page.

$1,000 except per share data  2017  2016 2015 2014 2013
Result        
Net sales 1,417,536  1,337,991  1,280,986  1,344,777  1,301,984
Operating income 153,419  98,827  179,498 161,693 57,477
Net income* 40,394 80,404 130,148 116,365 64,624
Basic earnings per share (EPS)* 0.18  0.34 0.56 0.50 0.28
Diluted earnings per share (EPS)* 0.17  0.34 0.55 0.48 0.27
Number of shares (in thousands)          
Common shares used to compute basic net income1 228,074  234,800 233,483 232,644 234,000
Common shares used to compute diluted net income2  233,009 238,993 238,647 242,806 243,400
Cash flow          
Cash flow from operations 286,779 341,602 317,497 287,965 258,957
Capital expenditures for property, plant and equipment 90,081 74,536 97,778 86,591 84,468
Free cash flow3  196,698  267,066 219,719 201,374 174,489
Balance sheet  
Total assets 5,038,516  4,308,194 4,179,117 4,454,372 4,088,392
Cash and cash equivalents 657,714 439,180 290,011 392,667 330,303
Total long-term liabilities, including current portion 2,174,087 1,393,668 1,343,616 1,490,114 1,024,389
Total equity 2,540,996 2,607,096 2,568,070 2,664,876 2,731,891
1 Weighted average number of common shares used to compute basic net income per common share

2 Weighted average number of common shares used to compute diluted net income per common share

3 Free cash flow(cash flow from operations less capital expenditures)

 * Attributable to the owners of QIAGEN N.V.

Related pages

FOLLOW US ON SOCIAL MEDIA